Sideroblastic anemia due to linezolid in a patient with a left ventricular assist device

Michelle C. Montpetit, Jamile L. Shammo, Jerome Loew, Stephanie Dunlap, Salpy V. Pamboukian, Alain Heroux

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

An acquired form of sideroblastic anemia has been described in association with several drugs, especially anti-microbial agents. A case of sideroblastic anemia is presented in a patient with a left ventricular assist device drive-line infection who was receiving linezolid, an antibiotic used for serious infections with gram-positive organisms. This patient's anemia resolved after discontinuation of the drug; he subsequently underwent an uncomplicated orthotopic heart transplant with no recurrence of anemia. As linezolid has been shown to have hematologic side effects, blood count monitoring is recommended in patients receiving this drug for long-term therapy.

Original languageEnglish (US)
Pages (from-to)1119-1122
Number of pages4
JournalJournal of Heart and Lung Transplantation
Volume23
Issue number9
DOIs
StatePublished - Sep 1 2004
Externally publishedYes

Fingerprint

Linezolid
Sideroblastic Anemia
Heart-Assist Devices
Anemia
Pharmaceutical Preparations
Anti-Infective Agents
Infection
Anti-Bacterial Agents
Transplants
Recurrence

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine
  • Transplantation

Cite this

Sideroblastic anemia due to linezolid in a patient with a left ventricular assist device. / Montpetit, Michelle C.; Shammo, Jamile L.; Loew, Jerome; Dunlap, Stephanie; Pamboukian, Salpy V.; Heroux, Alain.

In: Journal of Heart and Lung Transplantation, Vol. 23, No. 9, 01.09.2004, p. 1119-1122.

Research output: Contribution to journalArticle

Montpetit, Michelle C. ; Shammo, Jamile L. ; Loew, Jerome ; Dunlap, Stephanie ; Pamboukian, Salpy V. ; Heroux, Alain. / Sideroblastic anemia due to linezolid in a patient with a left ventricular assist device. In: Journal of Heart and Lung Transplantation. 2004 ; Vol. 23, No. 9. pp. 1119-1122.
@article{46d8537f68a84295873b83548dfdf58c,
title = "Sideroblastic anemia due to linezolid in a patient with a left ventricular assist device",
abstract = "An acquired form of sideroblastic anemia has been described in association with several drugs, especially anti-microbial agents. A case of sideroblastic anemia is presented in a patient with a left ventricular assist device drive-line infection who was receiving linezolid, an antibiotic used for serious infections with gram-positive organisms. This patient's anemia resolved after discontinuation of the drug; he subsequently underwent an uncomplicated orthotopic heart transplant with no recurrence of anemia. As linezolid has been shown to have hematologic side effects, blood count monitoring is recommended in patients receiving this drug for long-term therapy.",
author = "Montpetit, {Michelle C.} and Shammo, {Jamile L.} and Jerome Loew and Stephanie Dunlap and Pamboukian, {Salpy V.} and Alain Heroux",
year = "2004",
month = "9",
day = "1",
doi = "10.1016/j.healun.2003.07.028",
language = "English (US)",
volume = "23",
pages = "1119--1122",
journal = "Journal of Heart and Lung Transplantation",
issn = "1053-2498",
publisher = "Elsevier USA",
number = "9",

}

TY - JOUR

T1 - Sideroblastic anemia due to linezolid in a patient with a left ventricular assist device

AU - Montpetit, Michelle C.

AU - Shammo, Jamile L.

AU - Loew, Jerome

AU - Dunlap, Stephanie

AU - Pamboukian, Salpy V.

AU - Heroux, Alain

PY - 2004/9/1

Y1 - 2004/9/1

N2 - An acquired form of sideroblastic anemia has been described in association with several drugs, especially anti-microbial agents. A case of sideroblastic anemia is presented in a patient with a left ventricular assist device drive-line infection who was receiving linezolid, an antibiotic used for serious infections with gram-positive organisms. This patient's anemia resolved after discontinuation of the drug; he subsequently underwent an uncomplicated orthotopic heart transplant with no recurrence of anemia. As linezolid has been shown to have hematologic side effects, blood count monitoring is recommended in patients receiving this drug for long-term therapy.

AB - An acquired form of sideroblastic anemia has been described in association with several drugs, especially anti-microbial agents. A case of sideroblastic anemia is presented in a patient with a left ventricular assist device drive-line infection who was receiving linezolid, an antibiotic used for serious infections with gram-positive organisms. This patient's anemia resolved after discontinuation of the drug; he subsequently underwent an uncomplicated orthotopic heart transplant with no recurrence of anemia. As linezolid has been shown to have hematologic side effects, blood count monitoring is recommended in patients receiving this drug for long-term therapy.

UR - http://www.scopus.com/inward/record.url?scp=5144228188&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=5144228188&partnerID=8YFLogxK

U2 - 10.1016/j.healun.2003.07.028

DO - 10.1016/j.healun.2003.07.028

M3 - Article

C2 - 15454180

AN - SCOPUS:5144228188

VL - 23

SP - 1119

EP - 1122

JO - Journal of Heart and Lung Transplantation

JF - Journal of Heart and Lung Transplantation

SN - 1053-2498

IS - 9

ER -